Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology

Mariner Endosurgery, an innovative Canadian medical device company leading commercialization of computer-assisted medical devices for laparoscopic surgeries, announced today that it has received Investigational Testing Approval (ITA) from Health Canada. 
Receipt of the ITA enables the company to initiate clinical testing of Mariner’s LaparoGuard computer-assisted surgery platform which is planned to begin February 2018 at Hamilton General Hospital. 

“This represents an important step in advancing an exciting new technology that we believe offers great promise in mitigating risk and improving confidence by enhancing visualization for surgeons,” commented Dr. David Langlois, Chief Medical Officer of Mariner Endosurgery.

Founded in 2016, Mariner Endosurgery develops and commercializes innovative computer assisted medical devices for future facing laparoscopic surgeries.


 likes / 0 Comments
Share this post: